CoChat

Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection

Open access
Strobel, Lea, Johswich, Kay O. · 2018 · Scientific Reports

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Neisseria meningitidis(meningococcus) causes invasive diseases such as meningitis or septicaemia.Ex vivo infection of human whole blood is a valuable tool to study meningococcal virulence factors and the host innate immune responses. In order to consider effects of cellular mediators, the coagulation cascade must be inhibited to avoid clotting. There is considerable variation in the anticoagulants used among studies of N.meningitidis whole blood infections, featuring citrate, heparin or derivatives of hirudin, a polypeptide from leech saliva. Here, we compare the influence of these three different anticoagulants, and additionally Mg/EGTA, on host innate immune responses as well as on viability of N.meningitidis strains isolated from healthy carriers and disease cases, reflecting different sequence types and capsule phenotypes. We found that the anticoagulants significantly impact on cellular responses and, strain-dependently, also on bacterial survival. Hirudin does not inhibit complement and is therefore superior over the other anticoagulants; indeed hirudin-plasma most closely reflects the characteristics of serum during N.meningitidis infection. We further demonstrate the impact of heparin on complement activation on N.meningitidis and its consequences on meningococcal survival in immune sera, which appears to be independent of the heparin binding antigens Opc and NHBA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-28583-8

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Impact of anticoagulants on innate immune responses during whole blood infection with N. meningitidis. (a) C3d fragment deposition and (b) C5b9 deposition on strain MC58 after 30 min incubation in 5% serum or plasma anticoagulated as indicated below x-axis. ‘None’ refers to control without serum or plasma but stained with the respective antibodies. Left graph shows representative flow cytometry histogram, right graph plots geometric mean fluorescence intensity (MFI). (c) C5a release as measure of overall complement activation after 30 min of N. meningitidis infection (108 CFU/ml) with strain MC58 of whole blood anticoagulated as indicated below x-axis. Control refers to addition of RPMI medium instead of bacteria. (d) Oxidative burst response of neutrophils during infection with 107 CFU/ml of strain MC58 after 1 h of infection of whole blood anticoagulated with the indicated anticoagulants. RPMI medium was added as negative control instead of bacteria (control), 1 µM phorbol-12-myristate-13-acetate (PMA) served as positive control. Left panel shows representative histograms, right panel plots mean fluorescence intensity of a total of 6 independent experiments (6 donors). (e) Release of inflammatory mediators IL-8, TNF-α, IL-1β and IL-6 in whole blood infected with 106/ml of strain MC58 versus medium control after 4 h. All panels: *, **, *** indicates P < 0.05, 0.01 or 0.005 in one-way ANOVA applying Tukey’s post hoc test.
Figure 1 Impact of anticoagulants on innate immune responses during whole blood infection with N. meningitidis. (a) C3d fragment deposition and (b) C5b9 deposition on strain MC58 after 30 min incubation in 5% serum or plasma anticoagulated as indicated below x-axis. ‘None’ refers to control without serum or plasma but stained with the respective antibodies. Left graph shows representative flow cytometry histogram, right graph plots geometric mean fluorescence intensity (MFI). (c) C5a release as measure of overall complement activation after 30 min of N. meningitidis infection (108 CFU/ml) with strain MC58 of whole blood anticoagulated as indicated below x-axis. Control refers to addition of RPMI medium instead of bacteria. (d) Oxidative burst response of neutrophils during infection with 107 CFU/ml of strain MC58 after 1 h of infection of whole blood anticoagulated with the indicated anticoagulants. RPMI medium was added as negative control instead of bacteria (control), 1 µM phorbol-12-myristate-13-acetate (PMA) served as positive control. Left panel shows representative histograms, right panel plots mean fluorescence intensity of a total of 6 independent experiments (6 donors). (e) Release of inflammatory mediators IL-8, TNF-α, IL-1β and IL-6 in whole blood infected with 106/ml of strain MC58 versus medium control after 4 h. All panels: *, **, *** indicates P < 0.05, 0.01 or 0.005 in one-way ANOVA applying Tukey’s post hoc test.CC BY · PubMed Central
Figure 2 Influence of anticoagulants on survival of N. meningitidis strains (and N. lactamica) in whole blood infection. (a) Survival curves of various N. meningitidis strains and one N. lactamica strain (strain characteristics are in Supplementary Table S1; strains in red were isolated from IMD cases and strains in blue from asymptomatic carriers) in whole blood anticoagulated with different anticoagulants (see legend). Blood was drawn using monovettes containing the indicated anticoagulants from adult healthy donors with no history of meningococcal disease or vaccination and infected with 106 CFU/ml of the indicated bacterial strains. At indicated time points, viable bacteria were enumerated after plating serial dilutions onto blood agar plates and plotted as log10 of CFU/ml. Limit of detection was 500 CFU/ml (log10 = 2.7), values below detection limit were plotted as 100 CFU/ml (log10 = 2). Plotted are means ± SEM of results from 6–9 independent experiments (donors). As positive control, bacteria were incubated in BHI instead of blood. (b) Area under curve analysis of the growth curves from the individual experiments (donors). The detection limit is calculated from the detection limit in (A) (log10 of CFU/ml set to 2 for negative samples) multiplied by 6 h. *, **, ***, **** denote P < 0.05, 0.01, 0.005, 0.0005 in one-way ANOVA applying Bonferrroni’s post hoc test. ns, not significant. Please note that the arrangement of plots, grouped by capsule characteristics and/or sequence type of the infection strain as highlighted by the coloured boxes, is continuous throughout this study.
Figure 2 Influence of anticoagulants on survival of N. meningitidis strains (and N. lactamica) in whole blood infection. (a) Survival curves of various N. meningitidis strains and one N. lactamica strain (strain characteristics are in Supplementary Table S1; strains in red were isolated from IMD cases and strains in blue from asymptomatic carriers) in whole blood anticoagulated with different anticoagulants (see legend). Blood was drawn using monovettes containing the indicated anticoagulants from adult healthy donors with no history of meningococcal disease or vaccination and infected with 106 CFU/ml of the indicated bacterial strains. At indicated time points, viable bacteria were enumerated after plating serial dilutions onto blood agar plates and plotted as log10 of CFU/ml. Limit of detection was 500 CFU/ml (log10 = 2.7), values below detection limit were plotted as 100 CFU/ml (log10 = 2). Plotted are means ± SEM of results from 6–9 independent experiments (donors). As positive control, bacteria were incubated in BHI instead of blood. (b) Area under curve analysis of the growth curves from the individual experiments (donors). The detection limit is calculated from the detection limit in (A) (log10 of CFU/ml set to 2 for negative samples) multiplied by 6 h. *, **, ***, **** denote P < 0.05, 0.01, 0.005, 0.0005 in one-way ANOVA applying Bonferrroni’s post hoc test. ns, not significant. Please note that the arrangement of plots, grouped by capsule characteristics and/or sequence type of the infection strain as highlighted by the coloured boxes, is continuous throughout this study.CC BY · PubMed Central
Figure 3 Comparison of N. meningitidis and N. lactamica survival in serum, hirudin plasma and hirudin blood. (a) Survival curves of the bacterial strains in serum, plasma or whole blood were conducted in parallel as those in Fig. 2. Heat-inactivated serum from the same donors was probed in a separate infection experiment to avoid delays in infection experiments of fresh whole blood samples. (b) Log10 of CFU/ml at the 30 min time point for strain α14 highlighting the significant differences between serum and hirudin-plasma versus hirudin-blood, in which clearance is faster. (C) Log10 of CFU/ml at the indicated time points (top left in each graph) for strain α522 highlighting the significant differences between serum and hirudin-plasma vesus hirudin-blood, in which the bacteria are partially protected from clearance. *, **, **** denote P < 0.05, 0.01, 0.0005 in one-way ANOVA applying Bonferrroni’s post hoc test. ns, not significant.
Figure 3 Comparison of N. meningitidis and N. lactamica survival in serum, hirudin plasma and hirudin blood. (a) Survival curves of the bacterial strains in serum, plasma or whole blood were conducted in parallel as those in Fig. 2. Heat-inactivated serum from the same donors was probed in a separate infection experiment to avoid delays in infection experiments of fresh whole blood samples. (b) Log10 of CFU/ml at the 30 min time point for strain α14 highlighting the significant differences between serum and hirudin-plasma versus hirudin-blood, in which clearance is faster. (C) Log10 of CFU/ml at the indicated time points (top left in each graph) for strain α522 highlighting the significant differences between serum and hirudin-plasma vesus hirudin-blood, in which the bacteria are partially protected from clearance. *, **, **** denote P < 0.05, 0.01, 0.0005 in one-way ANOVA applying Bonferrroni’s post hoc test. ns, not significant.CC BY · PubMed Central
Figure 4 Influence of heparin concentration on C5b9 deposition and survival of N. meningitidis and N. lactamica in immune serum. (a) Representative histogram of C5b9 deposition onto strain MC58 incubated with 5% of immune serum in presence of different concentrations of heparin as indicated in legend. (b) Percentage of meningogocci positive for C5b9 as gated in histogram in (a) for the different N. meningitidis and N. lactamica strains plotted versus the heparin concentration as indicated under x-axis. Sera from two different donors in which no bacterial survival (all tested strains) in heparin-blood was found at 30 min were used as immune sera. (c) Survival curves of N. meningitidis and N. lactamica strains undiluted immune sera equipped with indicated concentrations of heparin versus BHI as positive control. Plotted are means ± SEM of three independent experiments (3 donors). *, **, *** denote P < 0.05, 0.01, 0.005 in one-way ANOVA applying Dunnett’s post hoc test versus ‘no heparin’ condition when comparing the area under the curve.
Figure 4 Influence of heparin concentration on C5b9 deposition and survival of N. meningitidis and N. lactamica in immune serum. (a) Representative histogram of C5b9 deposition onto strain MC58 incubated with 5% of immune serum in presence of different concentrations of heparin as indicated in legend. (b) Percentage of meningogocci positive for C5b9 as gated in histogram in (a) for the different N. meningitidis and N. lactamica strains plotted versus the heparin concentration as indicated under x-axis. Sera from two different donors in which no bacterial survival (all tested strains) in heparin-blood was found at 30 min were used as immune sera. (c) Survival curves of N. meningitidis and N. lactamica strains undiluted immune sera equipped with indicated concentrations of heparin versus BHI as positive control. Plotted are means ± SEM of three independent experiments (3 donors). *, **, *** denote P < 0.05, 0.01, 0.005 in one-way ANOVA applying Dunnett’s post hoc test versus ‘no heparin’ condition when comparing the area under the curve.CC BY · PubMed Central
Figure 5 Interaction of heparin with N. meningitidis surface proteins is not required for protection against complement deposition. (a) Western blot for detection of Opc expression by bacterial strains. The uncropped image is depicted in Supplementary Figure S4. (b) Whole-cell ELISA for detection of NHBA expression by bacterial strains. (c) Left panels: Representative histograms of C3d (upper graphs) or C5b9 (lower graphs) deposition onto strain MC58 incubated in 5% immune serum. In the ‘free heparin’ condition, heparin was added to the bacteria concommittantly with the immune serum; in the ‘bound heparin’ condition, bacteria were first incubated with heparin then washed and then the immune serum added. Heparin concentrations are indicated in the legend. Right panels: Mean fluorescence intensity of C3d deposition (upper graphs) or percentage of N. meningitidis with C5b9 deposition (lower graphs) as in histograms in left panels. The experiments were carried out with immune sera from 2 immune donors (same as in Fig. 4). (d) Binding of heparin to N. meningitidis as determined by flow cytometry using FITC-labeled heparin at 100 µg/ml following the same protocol for ‘free’ and ‘bound’ heparin as in (c). Specificity of FITC-labeled heparin binding is demonstrated by partial displacement by a 20-fold excess of unlabeled heparin; Further, binding of FITC-heparin to MC58ΔNHBA was monitored.
Figure 5 Interaction of heparin with N. meningitidis surface proteins is not required for protection against complement deposition. (a) Western blot for detection of Opc expression by bacterial strains. The uncropped image is depicted in Supplementary Figure S4. (b) Whole-cell ELISA for detection of NHBA expression by bacterial strains. (c) Left panels: Representative histograms of C3d (upper graphs) or C5b9 (lower graphs) deposition onto strain MC58 incubated in 5% immune serum. In the ‘free heparin’ condition, heparin was added to the bacteria concommittantly with the immune serum; in the ‘bound heparin’ condition, bacteria were first incubated with heparin then washed and then the immune serum added. Heparin concentrations are indicated in the legend. Right panels: Mean fluorescence intensity of C3d deposition (upper graphs) or percentage of N. meningitidis with C5b9 deposition (lower graphs) as in histograms in left panels. The experiments were carried out with immune sera from 2 immune donors (same as in Fig. 4). (d) Binding of heparin to N. meningitidis as determined by flow cytometry using FITC-labeled heparin at 100 µg/ml following the same protocol for ‘free’ and ‘bound’ heparin as in (c). Specificity of FITC-labeled heparin binding is demonstrated by partial displacement by a 20-fold excess of unlabeled heparin; Further, binding of FITC-heparin to MC58ΔNHBA was monitored.CC BY · PubMed Central
Figure 6 Influence of heparin on factor H binding to N. meningitidis in human serum. ELISA plates were coated with heat-killed bacteria and incubated with 5% heat-inactivated serum samples equipped with indicated concentrations of heparin. N. meningitidis bound fH was detected using anti-fH antibody. Plotted is the mean ± SEM of three independent experiments, serum from a different donor used in every experiment. *, **, *** denote P < 0.05, 0.01, 0.005, respectively, in one-way ANOVA applying Dunnett’s post hoc test comparing the different heparin concentrations with the ‘no heparin’ condition.
Figure 6 Influence of heparin on factor H binding to N. meningitidis in human serum. ELISA plates were coated with heat-killed bacteria and incubated with 5% heat-inactivated serum samples equipped with indicated concentrations of heparin. N. meningitidis bound fH was detected using anti-fH antibody. Plotted is the mean ± SEM of three independent experiments, serum from a different donor used in every experiment. *, **, *** denote P < 0.05, 0.01, 0.005, respectively, in one-way ANOVA applying Dunnett’s post hoc test comparing the different heparin concentrations with the ‘no heparin’ condition.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 2

  1. Edens, R. E., Linhardt, R. J. & Weiler, J. M. Heparin is not just an anticoagulant anymore: Six and one-half decades of studies on the ability of heparin to regulate complement activity. Complement Profiles 1, 96–120 (1993).
  2. Delany, I. et al. In Poster presented at 18th international pathogenic Neisseria conference (IPNC) meeting, September 9–14, Würzburg, Germany (2012) Poster013 (2012).

Cited by

See all 37

Metadata

Authors
Strobel, L., & Johswich, K. O.
Affiliations
University of Würzburg (DE)
Corresponding author
Johswich, Kay O.
Venue
Scientific Reports
Published
2018-07-05
Volume
8
Issue
1
Pages
10225-10225
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2809827390
Cited by
37
References
60
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 10 · 2021: 5 · 2020: 11 · 2019: 3 · 2018: 1
FWCI
4.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
Funders
Deutsche Forschungsgemeinschaft (JO 1204/2-1)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
Keywords
Neisseria meningitidis, anticoagulants, hirudin, heparin, citrate, innate immune response, complement activation, bacterial survival, sequence types, NHBA, coagulation cascade
MeSH terms
Animals, Anticoagulants, Bacterial Outer Membrane Proteins, Blood Cells, Carrier Proteins, Complement Activation, Heparin, Hirudins, Humans, Immunity, Innate, Meningococcal Infections, Models, Biological, Neisseria meningitidis, Citric Acid, Microbial Viability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection. https://app.cochat.ai/papers/10.1038/s41598-018-28583-8
The paper
Strobel, L., & Johswich, K. O. (2018). Anticoagulants impact on innate immune responses and bacterial survival in whole blood models of Neisseria meningitidis infection. Scientific Reports. https://doi.org/10.1038/s41598-018-28583-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.